Çѱ¹ÀÎ ÇǺΰúȯÀÚ¿¡¼ Methotrexate Ä¡·áÈ¿°ú ¹× ºÎÀÛ¿ë
Therapeutic Response and Adverse Effects of Methotrexate in Korean Patients with Dermatological Diseases
´ëÇÑÇǺΰúÇÐȸÁö 2014³â 52±Ç 4È£ p.237 ~ p.243
±è¿µÁö(Kim Young-Jee) - Chonnam National University Medical School Department of Dermatology
À±¼÷Á¤(Yun Sook-Jung) - Chonnam National University Medical School Department of Dermatology
ÀÌÁö¹ü(Lee Jee-Bum) - Chonnam National University Medical School Department of Dermatology
±è¼ºÁø(Kim Seong-Jin) - Chonnam National University Medical School Department of Dermatology
¿ø¿µÈ£(Won Young-Ho) - Chonnam National University Medical School Department of Dermatology
À̽Âö(Lee Seung-Chul) - Chonnam National University Medical School Department of Dermatology
Abstract
Background: Methotrexate (MTX) is a synthetic folic acid analogue with anti-proliferative and anti-inflammatoryproperties, and is prescribed for a variety of dermatological disorders. Objective: The aim of this study was to investigate the therapeutic responses, adverse effects, and risk factors ofMTX for dermatological use.
Methods: We retrospectively evaluated age, gender, underlying diseases, initial and cumulative doses of MTX,treatment duration, physician¡¯s global assessment (PGA) scores, and adverse effects in 200 dermatological patientstreated with MTX.
Results: Various dermatoses responded to MTX in the following order of effectiveness: psoriasis vulgaris, pustularpsoriasis, pityriasis lichenoides, atopic dermatitis, mycosis fungoides, and morphea. Adverse effects of MTX wereobserved in 64 of the 200 patients (32%) as follows: elevated liver function tests (LFTs) in 36 (18%), nausea orvomiting in 22 (11%), complete blood count abnormalities in 5 (2.5%), and a burning sensation over the lesion in4 (2%). All patients who showed abnormal LFTs were normalized after reducing or stopping MTX, and the meantime to normalization was 5.76 weeks. Liver fibrosis was not found. Risk factors for MTX-related adverse effectswere old age (p=0.028), skin disease (p=0.018), high initial dose of MTX (p=0.023), and high cumulative dose ofMTX (p=0.044).
Conclusion: Among various dermatoses, psoriasis showed an excellent response to MTX with relatively acceptablesafety in Koreans, but regular monitoring of MTX-related adverse effects is important. The risk factors for MTXrelatedadverse effects were old age, psoriasis, high initial dose, and high cumulative dose.
Å°¿öµå
Adverse effect, Methotrexate, Risk factor, Therapeutic response
KMID :
0363220140520040237
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)